Lupus & Connective Tissue Diseases
From the Journals
Phone outreach intervention feasible to reduce SLE readmissions
A nurse-led telephone-based intervention is low cost and feasible to reduce hospital readmissions for systemic lupus erythematosus.
Conference Coverage
Small-fiber polyneuropathy may underlie dysautonomia in ME/CFS
Autonomic dysfunction symptoms reported by ME/CFS patients in a pilot study overlap those commonly described by patients with autoimmune-...
From the Journals
Researchers home in on optimal biopsy length for giant cell arteritis
Review of Canadian records suggests 1.5-2 cm of tissue.
From the Journals
Age, smoking among leading cancer risk factors for SLE patients
While older age was a risk factor for both breast and nonmelanoma skin cancers, use of antimalarial drugs lowered the risk of both.
From the Journals
Sarcoidosis may raise long-term risk of heart failure and death
Patients with sarcoidosis have an increased risk of heart failure and other adverse outcomes, including all-cause mortality.
From the Journals
Cachexia affects more than half of lupus patients
SLE patients with intermittent cachexia had the greatest risk for organ damage over time.
Latest News
Updated EULAR/ACR criteria identify more lupus patients
Approximately 17% of cases of undifferentiated connective tissue disease could be challenged using new criteria.
Conference Coverage
Lenalidomide may be an answer for refractory cutaneous lupus
Mucocutaneous manifestations constitute 4 out of the 11 American College of Rheumatology classification criteria that clinicians use to make a...
From the Journals
Even a few days of steroids may be risky, new study suggests
A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.
Conference Coverage
Inhaled treprostinil improves walk distance in patients with ILD-associated pulmonary hypertension
Clinical worsening was reduced for patients with interstitial lung disease–associated pulmonary hypertension, compared with placebo.
From the Journals
Pulmonary function tests can’t substitute for high-resolution CT in early systemic sclerosis ILD screening
The results provide further evidence to show that high-resolution CT should be performed in all SSc patients to screen for the presence of ILD.